Coca-Cola proved to be the strongest US brand by posting a Brand Strength Index (BSI) score of 93.3, higher than Google, YouTube, Amazon, and Deloitte, according to a TradingPlatforms.com analysis.
The BSI rating also places Coca-Cola 2.2 points ahead of rival beverage company Pepsi.
The Brand Loyalty and Recommendation Forecast data, which reflects consumer perceptions, preferences, and intentions both online and offline, is the basis for the BSI score ranking.
Additionally, the renowned beverage business has a correspondingly prestigious AAA+ rating.
TradingPlatforms’ financial expert Edith Reads attributed Coca-Cola’s brand strength to the prominence of its core drink in the consumer’s mind, and recent innovations such as new flavors and lower sugar variants.
The BSI score, she continued, is a gauge of consumer loyalty, which can only be attained by having a remarkable level of brand awareness and high consumer approval ratings.
To satisfy consumer demand in a period of growing health consciousness, the company has concentrated on offering low-nutrition and alternative products like Coke Zero.
In a time of disrupted supply chains, it has also strategically chosen to use e-commerce to guarantee brand availability. In addition to its strong product strategy, which helped Coca-Cola ascend to the top, the company's digital strategy has also increased sales.


SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
Intel Reaffirms Role in Elon Musk’s Terafab Chip Project
Trump Signs Order to Cut Routine Childhood Vaccines
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
GSR Commits $100M to Hare Onchain Credit Vaults
Thailand Plans Dual-Class Shares to Revive IPO Market
Wall Street Rises as Oil Prices Ease, Nasdaq Hits Record
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Paramount Skydance Completes $110 Billion Warner Bros Discovery Deal
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
Oil Prices Rise as Hormuz Attacks Fuel Supply Fears
Ripple Expands Brevan Howard Deal With Prime Brokerage Services
UK House Prices Flat in September as Mortgage Rates Weigh
Constellation Brands Beats Q2 Estimates, Buys SpikedAde
Ukraine Faces $56 Billion Budget Gap as War Costs Soar 



